Projects

Pharmaceutical Sciences

bioscience workers in a lab
Anti-Infectives Development for National Institutes of Health

SRI is conducting preclinical development of treatments for diseases such as tuberculosis, West Nile virus, hepatitis, and biodefense pathogens and toxins.
scientist checking a batch of vaccines
Needle-Free Transmucosal Drug Delivery System

SRI has patented a novel approach to vaccine delivery that is safe for pediatric use, eliminating the need for painful injections.
scientist working with a chelating agent
Oral Formulation of DTPA to Counter Radiation Exposure

A new oral version of a known chelating agent can defend against mass radiation exposure in a terrorist attack.
gloved hand catching pill capsules coming out of a dispenser
SMARTT Projects: Treatments for Lung, Heart, Blood Diseases

Through a broad range of services for the National Institutes of Health, SRI is accelerating preclinical development of potential therapies for diseases that affect millions of people.
scientist looking through a microscope
Toxicological Evaluation of Novel Ligands Program

For the National Institute of Mental Health (NIMH), SRI performs preclinical safety and pharmacokinetics studies for brain imaging agents and drugs to treat mental illnesses.